吲哚并咔唑

5-苯基-5，11-二氢吲哚[3，2-b]咔唑

CAS: 1316311-27-9 分子式: C₂₄H₁₆N₂ 分子量: 332.40

≥98%

期货货号: P769185

查看产品

价格与包装

技术标识符

SMILES: C1=CC=C(C=C1)N2C3=CC=CC=C3C4=CC5=C(C=C42)C6=CC=CC=C6N5
InChIKey: GPGGOIGDVKWSLJ-UHFFFAOYSA-N
InChI: 1S/C24H16N2/c1-2-8-16(9-3-1)26-23-13-7-5-11-18(23)20-14-22-19(15-24(20)26)17-10-4-6-12-21(17)25-22/h1-15,25H

Midostaurin (PKC412)

CAS: 120685-11-2 EC号: 848-383-0 化合物 CID: 9829523 分子式: C₃₅H₃₀N₄O₄ 分子量: 570.64

Moligand™ ? ≥99%

有现货货号: C769921

查看产品

价格与包装

技术标识符

IUPAC名称: N-[(2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N-methylbenzamide
SMILES: CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC
InChIKey: BMGQWWVMWDBQGC-IIFHNQTCSA-N
InChI: 1S/C35H30N4O4/c1-35-32(42-3)25(37(2)34(41)19-11-5-4-6-12-19)17-26(43-35)38-23-15-9-7-13-20(23)28-29-22(18-36-33(29)40)27-21-14-8-10-16-24(21)39(35)31(27)30(28)38/h4-16,25-26,32H,17-18H2,1-3H3,(H,36,40显示更多

(5R,15'S,18'R)-3-(2-methoxyethyl)-15'-methylspiro[1,3-oxazolidine-5,16'-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaene]-2,3',4-trione

化合物 CID: 91824201 分子式: C₃₀H₂₄N₄O₆ 分子量: 536.5

期货货号: R671305

查看产品

价格与包装

技术标识符

IUPAC名称: (5R,15'S,18'R)-3-(2-methoxyethyl)-15'-methylspiro[1,3-oxazolidine-5,16'-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaene]-2,3',4-tr显示更多
SMILES: CC12C3(CC(O1)N4C5=CC=CC=C5C6=C7C(=C8C9=CC=CC=C9N2C8=C64)CNC7=O)C(=O)N(C(=O)O3)CCOC
InChIKey: SHWPFRVVBIKGAT-LYWBODIJSA-N
InChI: 1S/C30H24N4O6/c1-29-30(27(36)32(11-12-38-2)28(37)40-30)13-20(39-29)33-18-9-5-3-7-15(18)22-23-17(14-31-26(23)35)21-16-8-4-6-10-19(16)34(29)25(21)24(22)33/h3-10,20H,11-14H2,1-2H3,(H,31,35)/t20-,29+,30+/显示更多

O-Desmethyl Midostaurin

CAS: 740816-86-8 化合物 CID: 11261445 分子式: C₃₄H₂₈N₄O₄ 分子量: 556.61

期货货号: O646451

查看产品

价格与包装

技术标识符

IUPAC名称: N-[(2S,3R,4R,6R)-3-hydroxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N-methylbenzamide
SMILES: CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)O
InChIKey: PXOCRDZEEXVZQC-AFUPZKSLSA-N
InChI: 1S/C34H28N4O4/c1-34-31(39)24(36(2)33(41)18-10-4-3-5-11-18)16-25(42-34)37-22-14-8-6-12-19(22)27-28-21(17-35-32(28)40)26-20-13-7-9-15-23(20)38(34)30(26)29(27)37/h3-15,24-25,31,39H,16-17H2,1-2H3,(H,35,40显示更多

pegcantratinib

CAS: 1233363-33-1 化合物 CID: 132494168

Moligand™ ?

期货货号: P612675

查看产品

价格与包装

技术标识符

IUPAC名称: 3-[2-(2-methoxyethoxy)ethyl]-15'-methylspiro[1,3-oxazolidine-5,16'-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaene]-2,3',4-trione
SMILES: CC12C3(CC(O1)N4C5=CC=CC=C5C6=C7C(=C8C9=CC=CC=C9N2C8=C64)CNC7=O)C(=O)N(C(=O)O3)CCOCCOC
InChIKey: MTDVEOMKVDOULD-UHFFFAOYSA-N
InChI: 1S/C32H28N4O7/c1-31-32(29(38)34(30(39)43-32)11-12-41-14-13-40-2)15-22(42-31)35-20-9-5-3-7-17(20)24-25-19(16-33-28(25)37)23-18-8-4-6-10-21(18)36(31)27(23)26(24)35/h3-10,22H,11-16H2,1-2H3,(H,33,37)

TTT-3002

化合物 CID: 92136143

Moligand™ ?

期货货号: T614576

查看产品

价格与包装

技术标识符

SMILES: CNC(=O)[C@@]1(N)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
InChIKey: DCAYZGCTSXLIHO-FYCNXDEQSA-N
InChI: 1S/C27H23N5O3/c1-26-27(28,25(34)29-2)11-18(35-26)31-16-9-5-3-7-13(16)20-21-15(12-30-24(21)33)19-14-8-4-6-10-17(14)32(26)23(19)22(20)31/h3-10,18H,11-12,28H2,1-2H3,(H,29,34)(H,30,33)/t18-,26+,27-/m0/s1
关联靶标: Receptor-type tyrosine-protein kinase FLT3, Leucine-rich repeat serine/threonine-protein kinase 2

Go 7874

CAS: 153207-86-4 化合物 CID: 3500

Moligand™ ?

期货货号: G610629

查看产品

价格与包装

技术标识符

SMILES: COc1ccc2c(c1)c1c3c(=O)[nH]c(=O)c3c3c(c1n2CC(CN(C)C)O)n(C)c1c3cccc1
InChIKey: NYBAPNLYWRMTJL-UHFFFAOYSA-N
InChI: 1S/C27H26N4O4/c1-29(2)12-14(32)13-31-19-10-9-15(35-4)11-17(19)21-23-22(26(33)28-27(23)34)20-16-7-5-6-8-18(16)30(3)24(20)25(21)31/h5-11,14,32H,12-13H2,1-4H3,(H,28,33,34)
关联靶标: Muscarinic acetylcholine receptor M3, Muscarinic acetylcholine receptor M4, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M1

5-苯基-5,8-二氢吲哚并[2,3-c]咔唑

CAS: 1637752-63-6 化合物 CID: 118509099 分子式: C₂₄H₁₆N₂ 分子量: 332.4

≥98%

有现货货号: P587542

查看产品

价格与包装

技术标识符

IUPAC名称: 9-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene
SMILES: C1=CC=C(C=C1)N2C3=C(C4=CC=CC=C42)C5=C(C=C3)NC6=CC=CC=C65
InChIKey: NDGWKRXBXFUTMQ-UHFFFAOYSA-N
InChI: 1S/C24H16N2/c1-2-8-16(9-3-1)26-21-13-7-5-11-18(21)24-22(26)15-14-20-23(24)17-10-4-6-12-19(17)25-20/h1-15,25H

5,12-二氢吲哚并[3,2-a]咔唑

CAS: 111296-91-4 分子式: C₁₈H₁₂N₂ 分子量: 256.30

≥97%

有现货货号: D586381

查看产品

价格与包装

技术标识符

IUPAC名称: 5,12-dihydroindolo[3,2-c]carbazole
SMILES: C1=CC=C2C(=C1)C3=C(N2)C4=C(C=C3)NC5=CC=CC=C54
InChIKey: QQWXDAWSMPLECU-UHFFFAOYSA-N
InChI: 1S/C18H12N2/c1-3-7-14-11(5-1)12-9-10-16-17(18(12)20-14)13-6-2-4-8-15(13)19-16/h1-10,19-20H

11-(4,6-二苯基-1,3,5-三嗪-2-基)-11,12-二氢-10-苯并吲哚并[2,3-A]咔唑

CAS: 1024598-01-3 分子式: C₃₉H₂₅N₂₅ 分子量: 563.65

≥99%

有现货货号: D493800

查看产品

价格与包装

技术标识符

IUPAC名称: 12-(4,6-diphenyl-1,3,5-triazin-2-yl)-11-phenylindolo[2,3-a]carbazole
SMILES: C1=CC=C(C=C1)C2=NC(=NC(=N2)N3C4=CC=CC=C4C5=C3C6=C(C=C5)C7=CC=CC=C7N6C8=CC=CC=C8)C9=CC=CC=C9
InChIKey: VBJWDGGEJNGTET-UHFFFAOYSA-N
InChI: 1S/C39H25N5/c1-4-14-26(15-5-1)37-40-38(27-16-6-2-7-17-27)42-39(41-37)44-34-23-13-11-21-30(34)32-25-24-31-29-20-10-12-22-33(29)43(35(31)36(32)44)28-18-8-3-9-19-28/h1-25H

星形孢菌素

CAS: 62996-74-1 EC号: 613-127-7 化合物 CID: 44259 分子式: C₂₈H₂₆N₄O₃ 分子量: 466.53

Moligand™ ? 10mM in DMSO

有现货货号: S425192

查看产品

价格与包装

技术标识符

IUPAC名称: (2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one
SMILES: CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)NC)OC
InChIKey: HKSZLNNOFSGOKW-FYTWVXJKSA-N
InChI: 1S/C28H26N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h4-11,17,20,26,29H,12-13H2,1-3H3,(H,30,33)/t17-,20-,26-,28+/m1/s1
关联靶标: Cyclin-dependent kinase 1, Peripheral plasma membrane protein CASK, Tyrosine-protein kinase CSK, Serine/threonine-protein kinase/endoribonuclease IRE2, Serine/threonine-protein kinase/endoribonuclease IRE1, Ephrin type-A receptor 4, Ephrin type-B receptor 1, Receptor tyrosine-protein kinase erbB-4, Ephrin type-A receptor 5, Receptor tyrosine-protein kinase erbB-2, Dual specificity tyrosine-phosphorylation-regulated kinase 1B, Dual specificity tyrosine-phosphorylation-regulated kinase 3, eIF-2-alpha kinase GCN2, Myotonin-protein kinase, Dual specificity tyrosine-phosphorylation-regulated kinase 1A, Discoidin domain-containing receptor 2, Dual serine/threonine and tyrosine protein kinase, Epidermal growth factor receptor, Focal adhesion kinase 1, Ephrin type-A receptor 3, Macrophage colony-stimulating factor 1 receptor, Casein kinase II subunit alpha', Death-associated protein kinase 3, Cyclin-dependent kinase 16, Cyclin-dependent kinase 4, Serine/threonine-protein kinase DCLK3, Cyclin-dependent kinase 2, Death-associated protein kinase 2, Epithelial discoidin domain-containing receptor 1, Death-associated protein kinase 1, Proto-oncogene tyrosine-protein kinase receptor Ret, Retinoblastoma-associated protein, Protein odd-skipped-related 1, Serine/threonine-protein kinase PAK 5, cAMP-dependent protein kinase catalytic subunit PRKX, Rhodopsin kinase, Serine/threonine-protein kinase Sgk2, SRSF protein kinase 1, Serine/threonine-protein kinase Sgk1, Serine/threonine-protein kinase Sgk3, Proto-oncogene tyrosine-protein kinase Src, Rho-associated protein kinase 2, Serine/threonine-protein kinase SBK1, Lysine--tRNA ligase, Uncharacterized serine/threonine-protein kinase SBK3, Rho-associated protein kinase 1, Proto-oncogene tyrosine-protein kinase ROS, Serine/threonine-protein kinase 17A, Serine/threonine-protein kinase 38-like, Serine/threonine-protein kinase 25, Serine/threonine-protein kinase 26, Serine/threonine-protein kinase 10, Serine/threonine-protein kinase 33, STE20/SPS1-related proline-alanine-rich protein kinase, Serine/threonine-protein kinase 3, Serine/threonine-protein kinase 17B, Serine/threonine-protein kinase 32B, Serine/threonine-protein kinase 24, Serine/threonine-protein kinase 38, Serine/threonine-protein kinase 4, Tyrosine-protein kinase TXK, Vascular endothelial growth factor receptor 3, Tyrosine-protein kinase Yes, Tyrosine-protein kinase receptor TYRO3, Non-receptor tyrosine-protein kinase TYK2, Interleukin-1 receptor-associated kinase 4, Serine/threonine-protein kinase ICK, Interleukin-1 receptor-associated kinase 1, Inhibitor of nuclear factor kappa-B kinase subunit epsilon, Inhibitor of nuclear factor kappa-B kinase subunit alpha, Inhibitor of nuclear factor kappa-B kinase subunit beta, Tyrosine-protein kinase FRK, Tyrosine-protein kinase Fyn, Ephrin type-A receptor 6, Serine/threonine-protein kinase haspin, Calcium/calmodulin-dependent protein kinase kinase 2, Tyrosine-protein kinase Fer, Receptor-type tyrosine-protein kinase FLT3, Cyclin-G-associated kinase, Fibroblast growth factor receptor 1, Fibroblast growth factor receptor 2, Tyrosine-protein kinase Fes/Fps, Protein-tyrosine kinase 2-beta, Fibroblast growth factor receptor 3, Tyrosine-protein kinase Fgr, Glucokinase, Homeodomain-interacting protein kinase 1, Interleukin-1 receptor-associated kinase 3, Calcium/calmodulin-dependent protein kinase type 1B, Calcium/calmodulin-dependent protein kinase type 1D, Calcium/calmodulin-dependent protein kinase type 1G, Insulin-like growth factor 1 receptor, Maternal embryonic leucine zipper kinase, Tyrosine-protein kinase ITK/TSK, Tyrosine-protein kinase JAK3, cAMP-dependent protein kinase catalytic subunit beta, cAMP-dependent protein kinase catalytic subunit gamma, Calcium/calmodulin-dependent protein kinase type II subunit beta, Tyrosine-protein kinase Mer, Testis-specific serine/threonine-protein kinase 1, Thioredoxin reductase 1, cytoplasmic, Serine/threonine-protein kinase tousled-like 2, SNF-related serine/threonine-protein kinase, Non-receptor tyrosine-protein kinase TNK1, Serine/threonine-protein kinase SIK1, Serine/threonine-protein kinase SIK2, TRAF2 and NCK-interacting protein kinase, Serine/threonine-protein kinase TBK1, Serine/threonine-protein kinase TAO1, Tyrosine-protein kinase Tec, Serine/threonine-protein kinase TAO2, Serine/threonine-protein kinase TAO3, Serine/threonine-protein kinase tousled-like 1, Serine/threonine-protein kinase SIK3, STE20-like serine/threonine-protein kinase, Testis-specific serine/threonine-protein kinase 2, Testis-specific serine/threonine-protein kinase 3, Serine/threonine-protein kinase PLK4, Serine/threonine-protein kinase pim-1, Serine/threonine-protein kinase N3, Serine/threonine-protein kinase N1, Platelet-derived growth factor receptor alpha, Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform, Serine/threonine-protein kinase pim-2, Serine/threonine-protein kinase pim-3, Phosphorylase b kinase gamma catalytic chain, liver/testis isoform, Platelet-derived growth factor receptor beta, [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial, Inactive tyrosine-protein kinase PEAK1, Serine/threonine-protein kinase N2, cGMP-dependent protein kinase 1, Ribosomal protein S6 kinase beta-1, Misshapen-like kinase 1, MAP kinase-interacting serine/threonine-protein kinase 2, Serine/threonine-protein kinase LATS1, cGMP-dependent protein kinase 2, Protein kinase C delta type, Ribosomal protein S6 kinase alpha-1, Ribosomal protein S6 kinase alpha-2, Tyrosine-protein kinase SYK, Protein kinase C beta type, Serine/threonine-protein kinase D2, Protein kinase C epsilon type, Ribosomal protein S6 kinase alpha-6, Mitogen-activated protein kinase 15, Serine/threonine-protein kinase LATS2, Protein kinase C eta type, Ribosomal protein S6 kinase alpha-5, Serine/threonine-protein kinase D1, Protein kinase C iota type, Mitogen-activated protein kinase kinase kinase 15, Serine/threonine-protein kinase MARK2, Dual specificity mitogen-activated protein kinase kinase 2, Dual specificity mitogen-activated protein kinase kinase 3, Mitogen-activated protein kinase kinase kinase kinase 2, Serine/threonine-protein kinase Nek8, LIM domain kinase 1, Mitogen-activated protein kinase kinase kinase 19, Mitogen-activated protein kinase kinase kinase 10, Tyrosine-protein kinase Lck, Leukocyte tyrosine kinase receptor, Mitogen-activated protein kinase kinase kinase 12, Mitogen-activated protein kinase kinase kinase kinase 1, MAP/microtubule affinity-regulating kinase 3, MAP/microtubule affinity-regulating kinase 4, Mitogen-activated protein kinase kinase kinase kinase 3, Leucine-rich repeat serine/threonine-protein kinase 2, Serine/threonine-protein kinase Nek1, Mitogen-activated protein kinase kinase kinase kinase 4, Mitogen-activated protein kinase kinase kinase kinase 5, Mitogen-activated protein kinase kinase kinase 11, Mitogen-activated protein kinase kinase kinase 2, Mitogen-activated protein kinase kinase kinase 3, Serine/threonine-protein kinase MAK, Dual specificity mitogen-activated protein kinase kinase 6, Tyrosine-protein kinase JAK1, Serine/threonine-protein kinase MRCK alpha, Tyrosine-protein kinase Lyn, Mitogen-activated protein kinase kinase kinase 5, Dual specificity mitogen-activated protein kinase kinase 4, Cytochrome P450 11B2, mitochondrial, BMP-2-inducible protein kinase, Serine/threonine-protein kinase B-raf, Serine/threonine-protein kinase BRSK2, Tyrosine-protein kinase BTK, Serine/threonine-protein kinase BRSK1, Cytoplasmic tyrosine-protein kinase BMX, Tyrosine-protein kinase Blk, Aurora kinase A, Aurora kinase B, Aurora kinase C, Cyclin-dependent kinase 3, Tyrosine-protein kinase ZAP-70, Vascular endothelial growth factor receptor 1, Vascular endothelial growth factor receptor 2, AP2-associated protein kinase 1, Activated CDC42 kinase 1, Muscarinic acetylcholine receptor M4, Muscarinic acetylcholine receptor M2, Tyrosine-protein kinase ABL2, Tyrosine-protein kinase ABL1, RAC-gamma serine/threonine-protein kinase, Muscarinic acetylcholine receptor M1, ALK tyrosine kinase receptor, RAC-beta serine/threonine-protein kinase, RAC-alpha serine/threonine-protein kinase, 5'-AMP-activated protein kinase catalytic subunit alpha-1, 5'-AMP-activated protein kinase catalytic subunit alpha-2, Serine/threonine-protein kinase Chk1, Serine/threonine-protein kinase Chk2, Serine/threonine-protein kinase 32A, Tyrosine-protein kinase receptor UFO, Serine/threonine-protein kinase ULK1, Serine/threonine-protein kinase ULK2, Serine/threonine-protein kinase ULK3, Dual specificity protein kinase CLK1, Dual specificity protein kinase CLK2, Dual specificity protein kinase CLK4, Glycogen synthase kinase-3 beta, Glycogen synthase kinase-3 alpha, Tyrosine-protein kinase HCK, Mast/stem cell growth factor receptor Kit, Calcium/calmodulin-dependent protein kinase kinase 1, G protein-coupled receptor kinase 5, Insulin receptor-related protein, Insulin receptor, NUAK family SNF1-like kinase 2, Serine/threonine-protein kinase PAK 4, Serine/threonine-protein kinase PAK 6, PAS domain-containing serine/threonine-protein kinase, Serine/threonine-protein kinase PAK 1, Serine/threonine-protein kinase PAK 2, Serine/threonine-protein kinase PAK 3, NUAK family SNF1-like kinase 1, Myosin light chain kinase 2, skeletal/cardiac muscle, BDNF/NT-3 growth factors receptor, High affinity nerve growth factor receptor, NT-3 growth factor receptor, NADPH oxidase 4, Calcium/calmodulin-dependent protein kinase type 1, Calcium/calmodulin-dependent protein kinase type II subunit alpha, Calcium/calmodulin-dependent protein kinase type II subunit delta, Calcium/calmodulin-dependent protein kinase type II subunit gamma, Tyrosine-protein kinase JAK2, cAMP-dependent protein kinase catalytic subunit alpha, Protein kinase C gamma type, Protein kinase C alpha type, Ribosomal protein S6 kinase beta-2, Mitogen-activated protein kinase 1, Mitogen-activated protein kinase 14, Protein kinase C theta type, Ribosomal protein S6 kinase alpha-3, Ribosomal protein S6 kinase alpha-4, Serine/threonine-protein kinase D3, Mitogen-activated protein kinase kinase kinase 9, Serine/threonine-protein kinase MARK1, Serine/threonine-protein kinase MRCK beta, Serine/threonine-protein kinase MRCK gamma, Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 5, Myosin-IIIb, Muscle, skeletal receptor tyrosine-protein kinase, Myosin light chain kinase, smooth muscle, 3-phosphoinositide-dependent protein kinase 1

Go 6976

CAS: 136194-77-9 分子式: C₂₄H₁₈N₄O 分子量: 378.43

Moligand™ ? 10mM in DMSO

有现货货号: G421374

查看产品

价格与包装

技术标识符

IUPAC名称: 3-(23-methyl-14-oxo-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-3-yl)propanenitrile
SMILES: CN1C2=CC=CC=C2C3=C4C(=C5C6=CC=CC=C6N(C5=C31)CCC#N)CNC4=O
InChIKey: VWVYILCFSYNJHF-UHFFFAOYSA-N
InChI: 1S/C24H18N4O/c1-27-17-9-4-2-7-14(17)20-21-16(13-26-24(21)29)19-15-8-3-5-10-18(15)28(12-6-11-25)23(19)22(20)27/h2-5,7-10H,6,12-13H2,1H3,(H,26,29)
关联靶标: Cyclin-dependent kinase 1, Epidermal growth factor receptor, Cyclin-dependent kinase 2, Cyclin-dependent-like kinase 5, Non-receptor tyrosine-protein kinase TYK2, Interleukin-1 receptor-associated kinase 4, Tyrosine-protein kinase ITK/TSK, Tyrosine-protein kinase JAK3, Serine/threonine-protein kinase PLK4, Protein kinase C beta type, Serine/threonine-protein kinase D2, Serine/threonine-protein kinase D1, Serine/threonine-protein kinase MARK2, MAP/microtubule affinity-regulating kinase 3, Aurora kinase B, Glycogen synthase kinase-3 beta, Protein kinase C gamma type, Protein kinase C alpha type, Ribosomal protein S6 kinase alpha-3, 3-phosphoinositide-dependent protein kinase 1

吲哚并咔唑

描述:

上级分类:

热门产品